| Sep 30, 2026 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | SELL-OPTIONS | — | $20.23 | $6.6M |
| Sep 15, 2026 | Melissa Epperly | DIRECTOR | SELL | 4.938K | $39.74 | $196K |
| Sep 15, 2026 | Meghan FitzGerald | DIRECTOR | SELL | 5.112K | $39.74 | $203K |
| Sep 8, 2026 | Meghan FitzGerald | — | SELL-OPTIONS | — | $24.35 | $622K |
| Aug 28, 2026 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | SELL-OPTIONS | — | $19.81 | $6.4M |
| Aug 19, 2026 | Mayukh Sukhatme | PRESIDENT & CIO | SELL-OPTIONS | — | $20.36 | $11.1M |
| Aug 14, 2026 | Mayukh Sukhatme | PRESIDENT & CIO | SELL-OPTIONS | — | $20.10 | $21.6M |
| Jul 27, 2026 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | SELL-OPTIONS | — | $19.40 | $6.2M |
| Jun 30, 2026 | Meghan FitzGerald | DIRECTOR | SELL-OPTIONS | — | $21.85 | $261K |
| Jun 29, 2026 | Melissa B Epperly | DIRECTOR | SELL-OPTIONS | — | $19.42 | $531K |
| Jun 26, 2026 | Keith Manchester | — | SELL | 1.638M | $34.46 | $56.4M |
| Jun 26, 2026 | Dan Gold | — | SELL | 1.438M | $34.32 | $49.4M |
| Jun 26, 2026 | QVT Financial LP | — | SELL | 1.438M | $34.32 | $49.4M |
| Jun 25, 2026 | Mayukh Sukhatme | PRESIDENT & CIO | SELL-OPTIONS | — | $18.98 | $30.3M |
| Jun 24, 2026 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | SELL-OPTIONS | — | $18.50 | $5.9M |
| May 20, 2026 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | SELL | 34.483K | $17.22 | $6.4M |
| Apr 20, 2026 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | SELL-OPTIONS | — | $16.72 | $5.1M |
| Apr 16, 2026 | Matthew Gline | CEO | SELL | 289.774K | $29.16 | $8.4M |
| Apr 8, 2026 | Jennifer Humes | CHIEF ACCOUNTING OFFICER | SELL | 13.538K | $28.37 | $384K |
